LAT1 expression in non-small cell lung cancer has been demonstrated by Takeuchi et al., and inhibition of LAT1 by 2-aminobicyclo-(2,2,1)-heptane-2-carboxylic acid (BCH) resulted in reduced lung cancer cell viability [27,28]. This evidence concerns the gene SLC7A5 and lung cancer.